Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Sponsor: Alpha Tau Medical LTD.
Listed as NCT04534127, this NA trial focuses on Mucosal Neoplasm of Oral Cavity and Skin Cancer and remains actively recruiting participants. Sponsored by Alpha Tau Medical LTD., it has been updated 11 times since 2020, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Mar 2025 — Present [monthly]
Recruiting NA
-
Dec 2024 — Mar 2025 [monthly]
Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Aug 2023 — Jun 2024 [monthly]
Recruiting NA
-
Jul 2022 — Aug 2023 [monthly]
Recruiting NA
-
Mar 2022 — Jul 2022 [monthly]
Recruiting NA
-
Feb 2021 — Mar 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Alpha Tau Medical LTD.
For direct contact, visit the study record on ClinicalTrials.gov .